CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo TreatmentAsian Corporate Newswire·Nov 4, 2026 at 09:05 AM00867-1.99%
China Medical System Unit Rxilient Medical Wins Singapore Approval for Vitiligo CreamPUBT·Nov 3, 2026 at 10:34 PM00867-1.99%
Regulatory Alarm Bells Ring as Lide Education Ownership Shifts Amid Hong Kong Microcap VolatilityGlobal Report·Oct 21, 2026 at 09:17 AM01449+4.00%00165+0.11%
Short-Selling Surge Reshapes Hong Kong Small-Cap LandscapeGlobal Report·Oct 6, 2026 at 10:15 AM00300-0.68%00384+0.72%
China Medical System says Singapore share transfer agent to rename to Ascentium Corporate Services from Oct. 1PUBT·Sep 30, 2026 at 04:04 PM00867-1.99%
HSBC Research Ratings, TPs on CN Pharmaceuticals (Table)AASTOCKS News·Sep 29, 2026 at 09:35 AMONC-2.36%01093+1.20%
HSBC Research: Pressure on China Pharma Firms' Domestic Business Shifts Focus to Global Pipeline Progress; HANSOH PHARMA Top PickAASTOCKS News·Sep 29, 2026 at 09:30 AM01093+1.20%01276-2.27%
CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in ChinaGlobeNewswire·Sep 9, 2026 at 09:41 AM00867-1.99%8A80.00%
China Medical System's TQH5528 Oral STAT6 Degrader Presented At ERS 2026CoinLive·Sep 8, 2026 at 10:05 AM00867-1.99%8A80.00%
CMS/8A8.SG): Innovative Drug Lumirix(R) Approved in China for Additional Indication of Atopic Dermatitis (AD)Asian Corporate Newswire·Sep 4, 2026 at 12:23 AM00867-1.99%8A80.00%
China Medical System wins China approval for ruxolitinib cream in atopic dermatitisPUBT·Sep 3, 2026 at 09:55 AM00867-1.99%8A80.00%